Facebook
X
LinkedIn
Forward
Managing Male OAB: Update for the APP
The American Urological Association is proud to offer Managing Male OAB: Update for the Advanced Practice Provider, a dynamic educational activity, featuring a multidisciplinary panel of experts, including a nurse practitioner, physician assistant, and urologist, that will build upon the success of previous AUA education in OAB. Based on the documented educational need, the AUA will update APPs on the latest advancements in the management of patients with OAB, specifically OAB associated with Benign Prostatic Hyperplasia (BPH).
This multi-format learning experience includes:
- A Live Virtual Webinar featuring a multidisciplinary expert panel in a lively, interactive discussion on the latest advancements in the management of patients with OAB, specifically OAB associated with Benign Prostatic Hyperplasia (BPH).
- An On-Demand Webcast available via AUAUniversity and the AUAUniversity YouTube channel for convenient access anytime, for up to one year.
ACKNOWLEDGEMENTS
Support provided by an independent educational grant from:
- Sumitomo Pharma America, Inc.
Target Audience
- APPs
Learning Objectives
After participating in this CME activity, participants will be able to:
- Counsel and treat patients with OAB by incorporating current evidence on its epidemiology, burden and association of OAB in men with BPH.
- Integrate into practice the principles for diagnosis, counseling and treatment of OAB based on the clinical recommendations from the 2024 AUA/SUFU Guideline including the application of the Guideline to men with OAB associated with BPH.
- Implement OAB treatment strategies that incorporate evidence-based knowledge and patient centered considerations, including efficacy and side effects of treatment.
- Differentiate OAB medications based on mechanisms of action, side effects, and contraindications.
- Evaluate and apply emerging evidence of the association of antimuscarinic medications with cognitive decline, especially in the frail patients with OAB, into clinical decision making.
Welcome and Introductions
Pre-test
Segment 1: OAB in Men with BPH: Insights from the 2024 AUA/SUFU Guideline
Segment 2: Clinical Evaluation – Differentiating Voiding vs. Storage Symptoms
Segment 3: Management Pathway for Storage + Voiding Symptoms
Segment 4: Medication Strategy—Evidence, Comfort, and Combination Therapy
Segment 5: Advanced & Procedural Options
Post-test
Wrap-up
| Name | Company Name | Relationship Type | End Date |
| Hughes, Corinna | No relevant financial relationships to disclose | ||
| Mogil, Adam G. | No relevant financial relationships to disclose | ||
| Nitti, Victor William | Bright Uro | Consultant or Advisor | Current |
| EG 427 | Consultant or Advisor | Current | |
| Abbvie | Consultant or Advisor | Current | |
EDUCATION COUNCIL DISCLOSURE
Education Council DTL 2025_1.pdf
COI REVIEW WORK GROUP DISCLOSURES
COI Review Workgroup DTL 2025_1.pdf
AUA Office of Education Staff has nothing to disclose.
All relevant financial relationships have been mitigated.